{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:21:49Z","timestamp":1748406109264,"version":"3.41.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"DOI":"10.7759\/cureus.84919","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:21:49Z","timestamp":1748388109000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Initial Symptoms and Clinical Outcomes in COVID-19"],"prefix":"10.7759","author":[{"given":"Eiki","family":"Ichihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kou","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nouso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Mitsumune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruto","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Aokage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson S","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al.. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020, 323:2052-9. 10.1001\/jama.2020.6775","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287501","article-title":"A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection","volume":"18","author":"Ichihara E","year":"2023","unstructured":"Ichihara E, Hasegawa K, Kudo K, et al.. A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection. PLoS One. 2023, 18:e0287501. 10.1371\/journal.pone.0287501","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine JP","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999, 94:496-509. 10.1080\/01621459.1999.10474144","journal-title":"J Am Stat Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780120803","article-title":"Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?","volume":"12","author":"Pepe MS","year":"1993","unstructured":"Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?. Stat Med. 1993, 12:737-51. 10.1002\/sim.4780120803","journal-title":"Stat Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-017-0131-y","article-title":"Propensity scores in pharmacoepidemiology: beyond the horizon","volume":"4","author":"Jackson JW","year":"2017","unstructured":"Jackson JW, Schmid I, Stuart EA. Propensity scores in pharmacoepidemiology: beyond the horizon. Curr Epidemiol Rep. 2017, 4:271-80. 10.1007\/s40471-017-0131-y","journal-title":"Curr Epidemiol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4135\/9781071802854","article-title":"","author":"Leite W","year":"2017","unstructured":"Leite W. Practical Propensity Score Methods Using R. SAGE Publications, Inc., Thousand Oaks (CA); 2017. 10.4135\/9781071802854"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It's not that simple","volume":"101","author":"Althouse AD","year":"2016","unstructured":"Althouse AD. Adjust for multiple comparisons? It's not that simple. Ann Thorac Surg. 2016, 101:1644-5. 10.1016\/j.athoracsur.2015.11.024","journal-title":"Ann Thorac Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2007.09.003","article-title":"Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood","volume":"57","author":"Tsukahara H","year":"2008","unstructured":"Tsukahara H, Ohta N, Tokuriki S, et al.. Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood. Metabolism. 2008, 57:215-20. 10.1016\/j.metabol.2007.09.003","journal-title":"Metabolism"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0300060517723183","article-title":"Blood asymmetric dimethylarginine and nitrite\/nitrate concentrations in short-stature children born small for gestational age with and without growth hormone therapy","volume":"46","author":"Nagasaka H","year":"2018","unstructured":"Nagasaka H, Morioka I, Takuwa M, et al.. Blood asymmetric dimethylarginine and nitrite\/nitrate concentrations in short-stature children born small for gestational age with and without growth hormone therapy. J Int Med Res. 2018, 46:761-72. 10.1177\/0300060517723183","journal-title":"J Int Med Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.12-71","article-title":"Thioredoxin-1 and oxidative stress status in pregnant women at early third trimester of pregnancy: relation to maternal and neonatal characteristics","volume":"52","author":"Nakatsukasa Y","year":"2013","unstructured":"Nakatsukasa Y, Tsukahara H, Tabuchi K, et al.. Thioredoxin-1 and oxidative stress status in pregnant women at early third trimester of pregnancy: relation to maternal and neonatal characteristics. J Clin Biochem Nutr. 2013, 52:27-31. 10.3164\/jcbn.12-71","journal-title":"J Clin Biochem Nutr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158370","article-title":"Increased oxidative stress and decreased citrulline in blood associated with severe novel coronavirus pneumonia in adult patients","volume":"25","author":"Tsuge M","year":"2024","unstructured":"Tsuge M, Ichihara E, Hasegawa K, et al.. Increased oxidative stress and decreased citrulline in blood associated with severe novel coronavirus pneumonia in adult patients. Int J Mol Sci. 2024, 25:10.3390\/ijms25158370","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423622000585","article-title":"COVID-19 disease severity to predict persistent symptoms: a systematic review and meta-analysis","volume":"23","author":"Dirican E","year":"2022","unstructured":"Dirican E, Bal T. COVID-19 disease severity to predict persistent symptoms: a systematic review and meta-analysis. Prim Health Care Res Dev. 2022, 23:e69. 10.1017\/S1463423622000585","journal-title":"Prim Health Care Res Dev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241541","article-title":"Factors associated with disease severity and mortality among patients with COVID-19: a systematic review and meta-analysis","volume":"15","author":"Chidambaram V","year":"2020","unstructured":"Chidambaram V, Tun NL, Haque WZ, et al.. Factors associated with disease severity and mortality among patients with COVID-19: a systematic review and meta-analysis. PLoS One. 2020, 15:e0241541. 10.1371\/journal.pone.0241541","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","volume":"26","author":"Malik P","year":"2021","unstructured":"Malik P, Patel U, Mehta D, et al.. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021, 26:107-8. 10.1136\/bmjebm-2020-111536","journal-title":"BMJ Evid Based Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253894","article-title":"Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis","volume":"16","author":"Melo AK","year":"2021","unstructured":"Melo AK, Milby KM, Caparroz AL, et al.. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis. PLoS One. 2021, 16:e0253894. 10.1371\/journal.pone.0253894","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder G","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020, 323:1775-6. 10.1001\/jama.2020.4683","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli CM","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et al.. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020, 369:m1966. 10.1136\/bmj.m1966","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson EJ","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020, 584:430-6. 10.1038\/s41586-020-2521-4","journal-title":"Nature"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359531-association-between-initial-symptoms-and-clinical-outcomes-in-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:21:49Z","timestamp":1748388109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359531-association-between-initial-symptoms-and-clinical-outcomes-in-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.84919","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}